
Micro- and nanoplastics (MNPs) released from food contact materials (FCMs) present a risk-assessment challenge because exposure depends not only on mass concentration but also on particle size, number, morphology, polymer identity, surface properties, aggregation, transformation, and co-migration of additives and non-intentionally added substances. Conventional approaches remain fragmented and are poorly suited to translating FCM-specific particle release into human-relevant internal dosimetry and mechanistic toxicity. This review proposes a particle-adapted next-generation risk assessment (NGRA) framework integrating FCM release characterization, gastrointestinal transformation and absorbed fraction, physiologically based toxicokinetic (PBK/PBTK) modelling, adverse outcome pathways (AOPs), and explainable artificial intelligence (XAI). The framework explicitly defines data hand-offs between modules, including particle-specific exposure metrics, internal particle burden, persistence and clearance parameters, key-event evidence, and model uncertainty. AOPs are used to organize mechanistic evidence rather than infer causality, while XAI is positioned as an interpretability and prioritization tool subject to applicability-domain assessment, external validation, reproducibility, and uncertainty analysis. Attention is given to distinguishing particle-mediated effects from those associated with co-migrating additives and non-intentionally added substances. Regulatory translation is considered in the context of FCM migration assessment and emerging NAM-based approaches. The framework provides a basis for evidence integration, testing prioritization, and future quantitative regulatory assessment of FCM-derived MNPs.
Carbonyl stress caused by the accumulation of advanced glycation end products (AGEs) and excessive methylglyoxal production may be involved in the development of various neurodegenerative diseases. Sulfite is an endogenous intermediate of sulfur metabolism that protects against oxidative stress in neurons; however, the effect of sulfite on carbonyl stress in neuronal cells remains unclear. In this study, we examined the effects of sulfite on MGO-induced toxicity in human neuroblastoma SH-SY5Y cells. Pretreatment with sulfite attenuated MGO-induced cell death and suppressed the accumulation of MG-H1, which is a major MGO-derived AGE. These effects were accompanied by increased intracellular cysteine and glutathione levels and were abolished under cysteine/cystine-depleted conditions, which indicates that the enhancement of intracellular glutathione availability is the major intracellular mechanism underlying sulfitemediated protection. In contrast, simultaneous treatment with sulfite suppressed MG-H1 formation, even in the absence of extracellular cysteine/cystine in SH-SY5Y cells. LC-MS/MS analysis revealed direct adduct formation between sulfite and MGO. These results indicate that sulfite modulates MGO-induced toxic responses in an in vitro neuronal cell model through glutathione-associated defense and direct extracellular sequestration of MGO.
Renal fibrosis plays a central role in the progression of chronic kidney disease (CKD). Previous studies have reported that the bile acid receptors farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5) can protect against fibrosis development. However, these studies primarily relied on animal models or cell monocultures. In animal models, systemic influences can obscure kidney-specific effects, whereas cell monocultures lack the complex multicellular interactions that characterize kidney fibrosis. Here, we investigated whether the antifibrotic effects of FXR and TGR5 activation are also present in a multicellular tissue-based fibrosis model, namely mouse precision-cut kidney slices (mPCKS). Our results demonstrated that several bile acid receptors, including FXR and TGR5, are expressed in mPCKS. In addition, treatment with the endogenous FXR agonist chenodeoxycholic acid (CDCA) effectively attenuated both culture- and TGF-beta-induced fibrosis, which was associated with reduced SMAD2/3 protein levels. Notably, this effect appeared to be independent of FXR and TGR5 signaling. In contrast, lithocholic acid induced apoptosis in mPCKS. However, it is uncertain whether this is mediated through TGR5. Together, our findings demonstrate that mPCKS can be used to study bile acid signaling in renal fibrosis and that CDCA directly attenuates fibrosis in murine kidney tissue.